Applied Therapeutics Inc.

NASDAQ: APLT · Real-Time Price · USD
0.48
-0.03 (-5.70%)
At close: Jul 25, 2025, 3:59 PM

Applied Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
455K 9.99M n/a n/a
Cost of Revenue
425K 353K 441K 415K
Gross Profit
30K 9.64M -441K -415K
Operating Income
-104.3M -64.53M -82.95M -105.62M
Interest Income
3.53M 1.37M 685K 555K
Pretax Income
-105.62M -119.76M -82.51M -105.58M
Net Income
-105.62M -119.76M -82.51M -105.58M
Selling & General & Admin
56.01M 20.62M 27.32M 43.05M
Research & Development
48.74M 53.91M 55.63M 62.57M
Other Expenses
n/a n/a -177K -521K
Operating Expenses
104.75M 74.53M 82.95M 105.62M
Interest Expense
n/a n/a n/a 555K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
104.75M 74.53M 82.95M 105.62M
Income Tax Expense
n/a n/a n/a -970K
Shares Outstanding (Basic)
139.53M 84.24M 37.83M 25.6M
Shares Outstanding (Diluted)
139.53M 84.24M 37.83M 25.6M
EPS (Basic)
-0.76 -1.42 -2.18 -4.12
EPS (Diluted)
-0.76 -1.42 -2.18 -4.12
EBITDA
-103.87M -64.53M -82.07M -105.17M
EBIT
-104.3M -64.53M -82.51M -105.58M
Depreciation & Amortization
426K 353K 441K 415K